
Transform Cell Therapy from Promise to Reality
Every Hour Matters
While thousands of new therapies race through development, most organizations still rely on fragmented, reactive operations that extend vein-to-vein time. Every hour of delay directly impacts patient outcomes. We help you build the foundation to master end-to-end operations – from workforce and technology to process and culture. The result? More patients receive life-saving treatments when they need them most.
The Impact is Real
Tomorrow's Challenges Demand Today's Solutions
What once took 8 years for FDA approval now happens in one. With thousands of cell therapies in development, organizations can't afford to wait months gathering use cases while critical opportunities slip away. Our proven approach eliminates delays that affect 60% of organizations.
What once took 8 years for FDA approval now happens in one. With thousands of cell therapies in development, organizations can't afford to wait months gathering use cases while critical opportunities slip away. Our proven approach eliminates delays that affect 60% of organizations.
Scaling up production can't mean scaling down quality. We've helped organizations manage complex manufacturing processes with hundreds of variables while reducing the rate of deviations and out-of-spec batches through real-time monitoring and prescriptive analytics.
Scaling up production can't mean scaling down quality. We've helped organizations manage complex manufacturing processes with hundreds of variables while reducing the rate of deviations and out-of-spec batches through real-time monitoring and prescriptive analytics.
Our approach has helped organizations transform 24-hour data delays into real-time availability, eliminate 75% of manual processes, and reduce costs by up to 80%, improving commercial viability and patient access.
Our approach has helped organizations transform 24-hour data delays into real-time availability, eliminate 75% of manual processes, and reduce costs by up to 80%, improving commercial viability and patient access.

Cell Therapy Requires a Different Approach
We must think fundamentally differently to make an impact. Zoom out to see interconnections across your value chain before diving into solutions. Operationalize knowledge, don’t just automate tasks. Create one governance framework that scales. Focus on sustainable value, not quick wins that create future technical debt.
Add the Capabilities You Need, Quickly
While others theorize about supply chains, we've helped reinvent them. Our experience transforming operations for global innovation leaders means we bring proven approaches from the world's most agile, efficient operations to the unique challenges of cell therapy.
We're not just starting our cell therapy journey. Our dedicated professionals are actively embedded in transforming operations for market leaders, which means you benefit from real-world experience scaling operations in this unique space.
Our Gartner Magic Quadrant-recognized NH360 Enterprise Connect platform enables end-to-end value chain mapping with pre-built models specifically for cell therapy. Combined with our deep expertise in AI, process intelligence, and machine learning, we help you create intelligent operations that continuously improve.
Our Work In Action






Our Work in Action



